Matt, Author at European Medical Journal - Page 5 of 212

EMJ Cardiology feature image

New Therapies for Patients Following a Worsening Heart Failure Event? What’s Next for Your Patients Following a Worsening Heart Failure Event?

Patients with HF embark on a vicious cycle characterised by progressive worsening over time, recurrent hospitalisations associated…

Editor’s Pick: Association Between the Hospital Readmissions Reduction Program and Heart Failure Subtype Readmissions and Mortality in the USA

The Hospital Readmissions Reduction Program (HRRP) was designed to penalise hospitals for excess readmission…

EMJ Cardiology feature image

2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

An engaging session on the newly revised European Society of Cardiology (ESC) guidelines for the diagnosis and treatment…

Biomarker-Based Guideline-Directed Medical Therapy of Heart Failure

The prevalence of heart failure (HF) worldwide is 64.34 million cases, and almost 10 million years have been lost due to HF-related disability…

Hydroxychloroquine- and Azithromycin-Induced Transient Left-Bundle Branch Block in a Patient with COVID-19

Since the emergence of the novel coronavirus (referred to as severe acute respiratory syndrome coronavirus 2 [SARS-Cov-2]) in December 2019 in Wuhan City, China, and up until now, several studies and trials have been conducted to manage infected patients…

The Great British Healthcare System

Jonathan talks to Dr Giles Bond-Smith, Emergency General, Hepato-Pancreatico-Biliary Surgeon, Oxford University Hospitals NHS Trust. Together, they compare the UK and US medical systems…

Help Them, You’re a Doctor

This week, Jonathan journeys through anecdotes to make an appeal to his fellow healthcare workers. He urges his colleagues to use their voice and take on more responsibility in encouraging COVID-19 vaccine uptake and prevention, one patient at a time.

ESMO 2021 AML symposium

ESMO 2021 Jazz Pharmaceuticals AML symposium

Insight beyond Phase 3: Does real-world evidence impact how we treat high-risk AML…

Matt Atkinson and Megan Reutin on Reuters Events Pharma 2021

We talk to Matt Atkinson, Global Projects Director, Reuters Events Pharma, and Megan Reutin, Global Head of Omnichannel Analytics, Grünenthal Group, about the upcoming Reuters Pharma 2021 Event.

The Brain, Death, and AI

In this episode, Dr Malaz Boustani shares his experience of migrating from Syria to the US, explores brain health and preservation, and discusses how he copes with his own fear of death.